Accelerated Atherosclerosis and Cardiovascular Toxicity Induced by Radiotherapy in Breast Cancer
- PMID: 37629488
- PMCID: PMC10455250
- DOI: 10.3390/life13081631
Accelerated Atherosclerosis and Cardiovascular Toxicity Induced by Radiotherapy in Breast Cancer
Abstract
The number of patients diagnosed with breast cancer and cardiovascular disease is continuously rising. Treatment options for breast cancer have greatly evolved, but radiotherapy (RT) still has a key role in it. Despite many advances in RT techniques, cardiotoxicity is one of the most important side effects. The new cardio-oncology guidelines recommend a baseline evaluation, risk stratification and follow-up of these patients. Cardiotoxicity induced by RT can be represented by almost all forms of cardiovascular disease, with atherosclerosis being the most frequent. An interdisciplinary team should manage these patients, in order to have maximum therapeutic effect and minimum cardiovascular toxicity. This review will summarize the current incidence, risk factors, mechanisms and follow-up of RT-induced cardiovascular toxicity.
Keywords: breast cancer; cancer; cardiovascular toxicity; radiotherapy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Cardiovascular Toxicity Induced by Vascular Endothelial Growth Factor Inhibitors.Life (Basel). 2023 Jan 29;13(2):366. doi: 10.3390/life13020366. Life (Basel). 2023. PMID: 36836722 Free PMC article. Review.
-
Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.Curr Oncol Rep. 2021 May 3;23(7):77. doi: 10.1007/s11912-021-01066-2. Curr Oncol Rep. 2021. PMID: 33937943 Free PMC article. Review.
-
Early detection and prediction of cardiotoxicity after radiation therapy for breast cancer: the BACCARAT prospective cohort study.Radiat Oncol. 2016 Apr 7;11:54. doi: 10.1186/s13014-016-0627-5. Radiat Oncol. 2016. PMID: 27056179 Free PMC article. Clinical Trial.
-
[What should a cardiologist know about the follow-up and management of a woman with breast cancer ?].Ann Cardiol Angeiol (Paris). 2022 Nov;71(5):304-308. doi: 10.1016/j.ancard.2022.07.007. Epub 2022 Sep 6. Ann Cardiol Angeiol (Paris). 2022. PMID: 36075766 French.
-
Genetic Background in Patients with Cancer Therapy-Induced Cardiomyopathy.J Clin Med. 2025 Feb 15;14(4):1286. doi: 10.3390/jcm14041286. J Clin Med. 2025. PMID: 40004816 Free PMC article. Review.
Cited by
-
The Role of Advanced Cardiac Imaging in Monitoring Cardiovascular Complications in Patients with Extracardiac Tumors: A Descriptive Review.J Cardiovasc Dev Dis. 2024 Dec 29;12(1):9. doi: 10.3390/jcdd12010009. J Cardiovasc Dev Dis. 2024. PMID: 39852287 Free PMC article. Review.
-
Cardiotoxicity in Breast Cancer: Impact of Clinical Classifications and Treatment on Heart Health.Cancers (Basel). 2024 Dec 23;16(24):4281. doi: 10.3390/cancers16244281. Cancers (Basel). 2024. PMID: 39766180 Free PMC article.
-
Radiation-Induced Endothelial Ferroptosis Accelerates Atherosclerosis via the DDHD2-Mediated Nrf2/GPX4 Pathway.Biomolecules. 2024 Jul 22;14(7):879. doi: 10.3390/biom14070879. Biomolecules. 2024. PMID: 39062593 Free PMC article.
-
Evaluation of Tumor Control and Normal Tissue Complication Probabilities in Patients Receiving Comprehensive Nodal Irradiation for Left-Sided Breast Cancer.Curr Oncol. 2024 May 31;31(6):3189-3198. doi: 10.3390/curroncol31060241. Curr Oncol. 2024. PMID: 38920725 Free PMC article.
-
Epidemiology, risk factors and mechanism of breast cancer and atrial fibrillation.Cardiooncology. 2024 Dec 23;10(1):92. doi: 10.1186/s40959-024-00298-y. Cardiooncology. 2024. PMID: 39716319 Free PMC article. Review.
References
-
- [(accessed on 17 May 2023)]. Available online: https://www.iarc.who.int/news-events/current-and-future-burden-of-breast...
-
- Lyon A.R., López-Fernández T., Couch L.S., Asteggiano R., Aznar M.C., Bergler-Klein J., Boriani G., Cardinale D., Cordoba R., Cosyns B., et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Eur. Heart J. 2022;43:4229–4361. doi: 10.1093/eurheartj/ehac244. - DOI - PubMed
-
- Jacob S., Camilleri J., Derreumaux S., Walker V., Lairez O., Lapeyre M., Bruguière E., Pathak A., Bernier M.-O., Laurier D., et al. Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: A dosimetric evaluation based on individually-determined radiation dose (BACCARAT study) Radiat. Oncol. 2019;14:29. doi: 10.1186/s13014-019-1234-z. - DOI - PMC - PubMed
-
- Reed G.W., Masri A., Griffin B.P., Kapadia S.R., Ellis S.G., Desai M.Y. Long-term mortality in patients with radiation-associated coronary artery disease treated with percu-taneous coronary intervention. Circ. Cardiovasc. Interv. 2016;9:e003483. doi: 10.1161/CIRCINTERVENTIONS.115.003483. - DOI - PubMed
-
- Tuohinen S.S., Skyttä T., Poutanen T., Huhtala H., Virtanen V., Kellokumpu-Lehtinen P.-L., Raatikainen P. Radiotherapy-induced global and regional differences in early-stage left-sided versus right-sided breast cancer patients: Speckle tracking echocardiography study. Int. J. Cardiovasc. Imaging. 2017;33:463–472. doi: 10.1007/s10554-016-1021-y. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources